Drug firm Pfizer today reported a net profit of Rs 34.6 crore for the quarter ended May 31, 2010, while its net sales stood at Rs 212.33 crore.
In a filing to the Bombay Stock Exchange, the company said the figures were not comparable with the year-ago period due to the amalgamation of Duchem Laboratories with itself, which became effective from December 1, 2008.
For the six months ended May 31, the company posted a net profit of Rs 77.14 crore, while net sales amounted to Rs 414.94 crore.
Shares of Pfizer today closed at Rs 1,212.45 on the BSE, up 0.62 per cent from the previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app